Clinical Trial Update: A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass [Phase 1]

View source ↗

Summary

Phase 1 study evaluating romosozumab on bone quality of the forearm in postmenopausal women with low bone mass has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia

Drugs mentioned

• Romosozumab (romosozumab)

Snippet

Sponsor: Amgen | Conditions: Osteopenia | Phase 1 | Status: COMPLETED | Results posted: 2019-07-05